Genmab A (GMAB) Long-Term Investments (2023 - 2025)
Genmab A (GMAB) has disclosed Long-Term Investments for 1 consecutive years, with $37.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments changed N/A year-over-year to $37.0 million, compared with a TTM value of $37.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $37.0 million, changed N/A over the prior year.
- Long-Term Investments was $37.0 million for Q4 2025 at Genmab A.
- Across five years, Long-Term Investments topped out at $37.0 million in Q4 2025 and bottomed at $37.0 million in Q4 2025.